Updated:
A drug test consent form is written permission for workplace drug testing. The form names the testing lab, the substances checked, and how long the permission lasts. Employers use it before pre-employment, post-incident, scheduled or random testing.
This page explains what the form includes, when employers use it, how to fill it out and sign it, and which federal rules apply to some employers.
Key facts
Build Your Document
Answer a few simple questions to make your document in minutes
Save and Print
Save progress and finish on any device, download and print anytime
Sign and Use
Your valid, lawyer-approved document is ready
A drug test consent form is an employee's signed authorization for a drug or alcohol screening, naming who tests, what they test for, and who sees the results. The form turns an employer's testing policy into one employee's documented agreement.
Searchers call it a drug testing consent form, a drug test authorization form, a drug screen consent form or an employee drug test form. All of these names describe the same document: a short release that the employee signs before a sample is taken.
The form does three jobs. It shows the employee knew about the test. It lets the lab release results to the employer. It shows which substances the employee agreed to have checked.
A drug test form for employment is signed before each kind of workplace test: screening a new hire, testing after an incident, scheduled testing, or random testing. The kind of test decides whether one-time or ongoing permission fits.
A pre-employment consent form is signed after the candidate accepts a job offer and before the start date, so the test result cannot color the hiring decision itself. Telling candidates about the test early, in the job posting or at the interview, avoids surprises.
A one-time authorization fits this test. The form names the lab, the panel of substances and the employer who receives the result.
A post-incident test follows an on-the-job accident or injury when the employer wants to know whether drugs or alcohol played a part. A reasonable suspicion test follows signs such as erratic behavior or visible symptoms of drug use.
Many employers collect ongoing consent at hiring so these tests can happen quickly. When no ongoing consent exists, the employee signs a one-time form before the sample is taken.
Scheduled testing is testing at set intervals, common in workplaces where staff handle drugs, alcohol or safety-sensitive equipment. An ongoing authorization covers every scheduled test, so the employee signs once.
Random testing selects employees by chance, often through a computer-generated list, and relies on an ongoing authorization signed in advance. The employer's policy explains how the selection works so employees see it as fair.
A drug test consent form includes the parties, the testing lab, the substances, the length of the permission and the employee's signature. Each part answers one question the employee or the lab will ask.
The substance list is a checkbox panel that limits the test to what the employee agreed to. The FormsPal form lists:
Only the boxes that are ticked belong to the test. An empty box tells the lab that substance is outside the consent.
The authorization box sets how long the consent lasts: one-time permission covers a single test, while ongoing permission covers later tests under the employer's policy. New hires and post-incident tests usually get the one-time box.
The ongoing box suits workplaces with random or scheduled testing. The form lets the employee revoke the ongoing permission, and what follows a revocation depends on the employer's policy.
The release clause is the employee's permission for the lab to send results to the named employer. Without this clause, the employer has the test but no clear sign that the employee agreed to share the outcome.
The release of liability clause says that the employee does not hold the employer or the lab responsible for carrying out the test the employee agreed to. The clause covers the testing itself, as described on the form.
The release of liability, like the whole form, is for non-DOT testing: under 49 CFR 40.27, an employer must not require a DOT-covered employee to sign a consent, release, waiver of liability, or indemnification agreement for any part of the DOT testing process.
The consent form is voluntary in nature: the employee reads it, ticks nothing outside the agreed test, and signs. The signature shows the employee knew the purpose, the lab and the substances before the sample was taken.
Voluntary consent works best when the employee gets a clear answer to a few questions before signing:
The form answers the first four. The employer's drug-free workplace policy answers the last two, so the employee gets a copy of the policy with the form.
Drug testing rules are a mix of federal rules for some employers and different rules from one place to the next. A consent form fits inside those rules; it does not replace them.
The Drug-Free Workplace Act, codified at 41 U.S.C. § 8102, covers federal contractors whose contracts exceed the simplified acquisition threshold, other than contracts for commercial products or commercial services. Under 41 U.S.C. § 8102, such a contractor agrees to provide a drug-free workplace by publishing a statement that the unlawful manufacture, distribution, dispensation, possession, or use of a controlled substance is prohibited in the workplace.
Under 41 U.S.C. § 8102, the contractor also establishes a drug-free awareness program that informs employees about the dangers of drug abuse in the workplace and available counseling and employee assistance programs. The text of 41 U.S.C. § 8102 does not mention drug testing or a consent form.
DOT drug testing rules sit in 49 CFR Part 40, and 49 CFR 40.191 defines a refusal to take a DOT drug test and its consequences. Under 49 CFR 40.191, an employee who refuses to take a DOT drug test incurs the consequences specified under DOT agency regulations.
Under 49 CFR 40.191, a refusal includes failing to provide a specimen for a required test or admitting to the collector that the specimen was adulterated or substituted. Under 49 CFR 40.191, an employee who leaves the collection site before the testing process begins for a pre-employment test is not deemed to have refused.
Testing rules beyond the federal ones above differ from place to place, and the sources behind this page name no single rule that covers every employer. Any employer is encouraged to consult the state laws before providing the pre-employment screening, as regulations can vary for specific states.

The drug test consent form is filled out in five parts: the date and names, the substances, the employer, the length of the authorization, and the signature. The steps below follow the form part by part.
The screenshots under each step show the FormsPal Drug Test template filled with sample entries in blue, so you can see where each answer goes. The names, addresses, dates and amounts are examples only.
The first lines of the form name the employee and the lab that will take the specimen, with its agents, representatives, affiliates and centers.



The checklist limits the test to the ticked substances, so it matches the panel the lab will run.


The rest of the checklist and the employer line complete the scope of the consent, naming the business that receives the result.


The authorization box sets one-time or ongoing consent, and only one of the two boxes is ticked on each signed form.


The signature block on the second page makes the consent effective, and the signing date usually marks when the permission starts.


A signed consent form goes to the lab and to the employer's personnel folder, and the employee keeps a copy. The steps below keep the paperwork and the test in line.
A drug test consent form is one employee's permission for testing, while a drug-free workplace policy is the employer's set of rules for everyone. Workplace drug testing templates usually include both.
The policy explains who is tested, when, by which method, how results stay confidential and what follows a positive result or a refusal. The consent form ties one employee to one test or to the policy's ongoing testing.
Other documents sit beside them. An employee handbook acknowledgment shows the employee received the policy. A general consent form covers permissions outside drug testing.
Yes, the form documents consent the employee chooses to give, so an employee can decline to sign it. What follows depends on the employer's policy for non-DOT testing. Under 49 CFR 40.27, a DOT employer may not require this kind of form at all, and under 49 CFR 40.191, declining to sign a non-DOT form is not a refusal to take a DOT test.
The drug test process starts with the signed form, then a sample at a lab or collection site. The person gives a urine, blood or saliva sample, and the lab checks it for the substances ticked on the form. In a non-DOT test, the lab then sends the result to the employer named in the release; in a DOT test, the lab reports only to the Medical Review Officer (49 CFR 40.97).
In a non-DOT test, the employer named on the form receives the results, because the release clause gives the lab permission to send them there. In a DOT test, under 49 CFR 40.97, the lab reports results directly, and only, to the Medical Review Officer, not to or through the employer.
Yes, the form lets the employee revoke ongoing permission, and what follows a revocation depends on the employer's policy. A written, dated notice to the employer shows when the ongoing authorization ended.
Three details on the form deserve a last look before printing: the name, the ticked boxes and the date.
Then print the form and sign it.
General information, not legal or tax advice.
